Improved colour blindness symptoms associated with recreational psychedelic use: Results from the Global Drug Survey 2017
Analysis of self-reports from the Global Drugs Survey 2017 found that 23 of 47 usable respondents described improved colour blindness after using psychedelics (commonly LSD and psilocybin), with some changes persisting from days to years. The authors present this as preliminary evidence and suggest a mechanism in which psychedelic-induced novel photisms become linked to pre-existing colour concepts via enhanced visual–linguistic cortical connectivity, recommending targeted follow-up studies.
Authors
- David Nutt
- Jason Ferris
Published
Abstract
It is well documented that psychedelic drugs can have a profound effect on colour perception. After previous research involving psychedelic drug ingestion, several participants had written to the authors describing how symptoms of their colour blindness had improved. The Global Drugs Survey runs the world’s largest annual online drug survey. In the Global Drugs Survey 2017, participants reporting the use of lysergic acid diethylamide or psilocybin in the last 12 months were asked, We have received reports from some people with colour-blindness that this improves after they use psychedelics. If you have experienced such an effect can you please describe it in the box below, say what drug you took and how long the effect lasted. We received 47 responses that could be usefully categorised of which 23 described improved colour blindness. Commonly cited drugs were LSD and psilocybin; however, several other psychedelic compounds were also listed. Some respondents cited that the changes in colour blindness persisted, from a period of several days to years. Improved colour blindness may be a result of new photisms experienced in the psychedelic state aligning with pre-existing concepts of colour to be ascribed a label. Connections between visual and linguistic cortical areas may be enhanced due to disorder in the brain’s neural connections induced by psychedelics allowing these new photisms and concepts to become linked. This paper provides preliminary data regarding improved colour blindness accompanying recreational psychedelic use which may be further investigated in future iterations of the Global Drugs Survey or in a stand-alone Global Drugs Survey-managed psychedelics survey.
Research Summary of 'Improved colour blindness symptoms associated with recreational psychedelic use: Results from the Global Drug Survey 2017'
Introduction
Historical and laboratory literature describes profound alterations to colour perception produced by psychedelic drugs, including changes to spectral patterns and hue discrimination. Such reports challenge simple models that treat colour vision as determined solely by retinal photoreceptors, because central processing can alter the experienced colour without changing retinal input. The authors also note anecdotal reports from prior research participants and online forums claiming that psychedelic use produced improvements in previously congenital colour-blind perception. Anthony and colleagues set out to collect preliminary, population-level data on whether recreational psychedelic use is associated with perceived improvements in colour blindness. Rather than a mechanistic experiment, the study used an exploratory item added to the Global Drug Survey 2017 to gather self-reported accounts about whether people who reported recent LSD or psilocybin use had experienced an improvement in their ability to distinguish colours and how long any change lasted. The stated aim was to assess whether this phenomenon occurs frequently enough to merit more detailed follow-up studies or a dedicated survey module.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Create a free account to open full-text PDFs.
Study Details
- Study Typeindividual
- Journal
- Compounds
- Authors
- APA Citation
Anthony, J., Winstock, A., Ferris, J., & Nutt, D. (2020). Improved colour blindness symptoms associated with recreational psychedelic use: Results from the Global Drug Survey 2017. Drug Science, Policy and Law, 6. https://doi.org/10.1177/2050324520942345
References (10)
Papers cited by this study that are also in Blossom
Bouso, J. C., Dos Santos, R. G., Hallak, J. E. · Neuroscience and Biobehavioral Reviews (2018)
Carhart-Harris, R. L., Leech, R., Shanahan, M. et al. · Frontiers in Human Neuroscience (2014)
Carhart-Harris, R. L., Nutt, D. J. · Journal of Psychopharmacology (2017)
Dolder, P. C., Schmid, Y., Müller, F. et al. · Neuropsychopharmacology (2016)
Luke, D. P., Terhune, D. B. · Frontiers in Psychology (2013)
Madsen, M. K., Fisher, P. M., Burmester, D. et al. · Neuropsychopharmacology (2019)
Martinotti, G., Santacroce, R., Pettorruso, M. et al. · Brain Sciences (2018)
Ray, T. S. · PLOS ONE (2010)
Rocha, J. M., Osório, F. L., Crippa, J. A. et al. · Therapeutic Advances in Psychopharmacology (2019)
Roseman, L., Demetriou, L., Wall, M. B. et al. · Neuropharmacology (2018)
Cited By (4)
Papers in Blossom that reference this study
Kovacevich, A., Weleff, J., Claytor, B. et al. · Journal of Psychoactive Drugs (2023)
Barnett, B. S., Sweat, N. W., Hendricks, P. S. · Drug Science Policy and Law (2023)
Kopra, E., Ferris, J. A., Winstock, A. R. et al. · Journal of Psychopharmacology (2023)
Shaw, L., Rea, K., Lachowsky, N. J. et al. · Journal of Psychoactive Drugs (2022)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.